What is Life Sciences Software?
The global life science software market is expected to witness high growth due to the increasing demand for efficient management of patient data. and The software used in life science enables users to increase efficacy and reduce the cost of deploying valuable IT infrastructure. For instant, a SaaS (Software as a Service) model for life science offers a pay per use model that provides more feasibility to store patient data. Also, factors such as a rise in frequent chronic diseases, increasing pressure to curb healthcare spending, and increasing focus on value-based medicine also result in the significant growth of this market.
The market study is broken down, by Application (Pharmaceuticals, Biotechnology and Others) and major geographies with country level break-up.
Leading key players are focusing on strategic partnerships to improve their products and services. Companies are focusing on increasing their client base to strengthen market position and to enhance product & service offerings. Analysts at AMA Research estimates that Players from United States will contribute to the maximum growth of Global Life Sciences Software market throughout the predicted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
QuintilesIMS Incorporated (United States), Autodesk Inc (United States), PAREXEL International Corporation (United States), Model N (United States), Dassault Systèmes (France), International Business Machines Corp (United States), SAP SE (Germany), Veeva Systems (United States) and Medidata Solutions, Inc (United States) are some of the key players that are part of study coverage.
Segmentation Overview
AdvanceMarketAnalytics has segmented the market of Global Life Sciences Software market by Type, Application and Region.
On the basis of geography, the market of Life Sciences Software has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2020. Europe on the other hand stood as second largest market due to the presence of key companies into the region and high technological advancement. If we see Market by Deployment Mode, the sub-segment i.e. Cloud-based will boost the Life Sciences Software market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Market Leaders and their expansionary development strategies
On 29th October 2019, Dassault Systèmes has announced the completion of its acquisition of Medidata Solutions, Inc. whose clinical expertise and cloud-based solutions power the smarter development and commercialization of treatments. and On 9th October 2019, Parexel, a leading provider of solutions to accelerate the development and delivery of innovative new therapies to improve world health, from Clinical through to Commercialization, and Datavant, the leader in helping healthcare organizations connect data, today announced a multi-year strategic partnership to enable the connection of real-world data across all clinical trials conducted by Parexel.
On 19th June 2019, Dassault Systèmes has announced its participation as lead investor in a 65 million Euros Series B financing for BioSerenity, a startup developing a comprehensive and efficient health solution involving textiles equipped with sensors and online telehealth services to diagnose and monitor chronic pathologies.
Market Trend
- Availability Of Big Data In the Life Science
- Increasing Adoption of Analytical Solution in Hospital & Clinics
Market Drivers
- Increasing the Requirement of Improvement of Operational Efficiency
- Growing Need for Improved Patient Care Delivery
Opportunities
- Continuous Technological Advancement in the Life Science Software
- Adoption of Merger & Acquisitions Strategies among Companies
Restraints
- High-Cost Associated with Life Science Software
Challenges
- Additional Infrastructure and Cost for Data Management
Key Target Audience
Information Technology (IT) Service Providers, Life Science Software Providers, System Integrators, Application Developers and Others
About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have the better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with purpose to understand companys positioning regarding market value, volume and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders etc. and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.